{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:08:04Z","timestamp":1760425684622,"version":"3.44.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.suc.2018.11.003","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T13:52:06Z","timestamp":1549806726000},"page":"185-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Autoimmune Diseases of the Biliary Tract"],"prefix":"10.1016","volume":"99","author":[{"given":"Christina W.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Ronnekleiv-Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suc.2018.11.003_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cld.2009.02.011","article-title":"Management of autoimmune and cholestatic liver disorders","volume":"13","author":"Krok","year":"2009","journal-title":"Clin Liver Dis"},{"issue":"2\u20133","key":"10.1016\/j.suc.2018.11.003_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12016-015-8484-9","article-title":"Unmet challenges in immune-mediated hepatobiliary diseases","volume":"48","author":"Beuers","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00261-016-0903-8","article-title":"Imaging of autoimmune biliary disease","volume":"42","author":"Yeh","year":"2017","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.suc.2018.11.003_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0676.1995.tb00110.x","article-title":"Prediction of prognosis of primary biliary cirrhosis in Japan","volume":"15","author":"Inoue","year":"1995","journal-title":"Liver"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12072-017-9830-1","article-title":"Primary biliary cholangitis: a comprehensive overview","volume":"11","author":"Lleo","year":"2017","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib7","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep.1840110504","article-title":"Sj\u00f6gren's syndrome in patients with primary biliary cirrhosis","volume":"11","author":"Tsianos","year":"1990","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.suc.2018.11.003_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/ard.60.11.1046","article-title":"Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients","volume":"60","author":"Marasini","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.suc.2018.11.003_bib9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.cgh.2013.02.016","article-title":"Primary sclerosing cholangitis: diagnosis, prognosis, and management","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.bpg.2011.10.009","article-title":"Pathogenesis of primary sclerosing cholangitis","volume":"25","author":"Pollheimer","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib11","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.suc.2018.11.003_bib14","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib15","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1568-9972(03)00030-2","article-title":"Primary sclerosing cholangitis","volume":"2","author":"Cullen","year":"2003","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11894-006-0067-8","article-title":"Primary sclerosing cholangitis: diagnosis and management","volume":"8","author":"Charatcharoenwitthaya","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"issue":"2","key":"10.1016\/j.suc.2018.11.003_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib20","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0016-5085(90)91096-O","article-title":"Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease","volume":"98","author":"Porayko","year":"1990","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.38.3.384","article-title":"Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass","volume":"38","author":"Bansi","year":"1996","journal-title":"Gut"},{"issue":"2\u20133","key":"10.1016\/j.suc.2018.11.003_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12016-014-8430-2","article-title":"IgG4-associated cholangitis: a comprehensive review","volume":"48","author":"Hubers","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"10.1016\/j.suc.2018.11.003_bib23","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.suc.2018.11.003_bib24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrgastro.2016.132","article-title":"IgG4-related hepatobiliary disease: an overview","volume":"13","author":"Culver","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","article-title":"Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012","volume":"19","author":"Ohara","year":"2012","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.suc.2018.11.003_bib27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MPA.0000000000000325","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011","volume":"44","author":"Kanno","year":"2015","journal-title":"Pancreas"},{"issue":"4","key":"10.1016\/j.suc.2018.11.003_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOG.0000000000000362","article-title":"IgG4-related disease of the biliary tract and pancreas: clinical and experimental advances","volume":"33","author":"Hubers","year":"2017","journal-title":"Curr Opin Gastroenterol"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.dld.2010.02.014","article-title":"Update on primary biliary cirrhosis","volume":"42","author":"Invernizzi","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.arcmed.2014.03.002","article-title":"HLA-DR polymorphism and primary biliary cirrhosis: evidence from a meta-analysis","volume":"45","author":"Li","year":"2014","journal-title":"Arch Med Res"},{"issue":"10","key":"10.1016\/j.suc.2018.11.003_bib32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ng.2395","article-title":"Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis","volume":"44","author":"Liu","year":"2012","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bmb\/ldv019","article-title":"Primary sclerosing cholangitis: a clinical update","volume":"114","author":"Williamson","year":"2015","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O'Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","author":"Fosby","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.suc.2018.11.003_bib36","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1136\/gutjnl-2016-313598","article-title":"Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis","volume":"67","author":"Alberts","year":"2018","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.suc.2018.11.003_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2018.11.003_bib38","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A\u00a0preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/gast.2001.25527","article-title":"A\u00a0functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis","volume":"121","author":"Satsangi","year":"2001","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.suc.2018.11.003_bib40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cgh.2008.03.016","article-title":"Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis","volume":"6","author":"Bergquist","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.suc.2018.11.003_bib41","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","article-title":"Immunoglobulin G4: an odd antibody","volume":"39","author":"Aalberse","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"5844","key":"10.1016\/j.suc.2018.11.003_bib42","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1126\/science.1144603","article-title":"Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange","volume":"317","author":"van der Neut Kolfschoten","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib43","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/hep.26232","article-title":"Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis","volume":"57","author":"Maillette de Buy Wenniger","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","article-title":"De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease","volume":"134","author":"Mattoo","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib45","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.suc.2018.11.003_bib46","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.suc.2018.11.003_bib47","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","article-title":"A\u00a0new clinicopathological entity of IgG4-related autoimmune disease","volume":"38","author":"Kamisawa","year":"2003","journal-title":"J\u00a0Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/BOR.0b013e3283413469","article-title":"Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis","volume":"23","author":"Sah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.suc.2018.11.003_bib49","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/gut.2008.150979","article-title":"Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study","volume":"57","author":"Moon","year":"2008","journal-title":"Gut"},{"issue":"Suppl 18","key":"10.1016\/j.suc.2018.11.003_bib50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00535-007-2049-5","article-title":"How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria","volume":"42","author":"Okazaki","year":"2007","journal-title":"J\u00a0Gastroenterol"},{"issue":"8","key":"10.1016\/j.suc.2018.11.003_bib51","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1097\/MPA.0b013e3182706ed5","article-title":"The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for autoimmune pancreatitis","volume":"41","author":"Shimosegawa","year":"2012","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","article-title":"Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited","volume":"36","author":"Paumgartner","year":"2002","journal-title":"Hepatology"},{"issue":"8537","key":"10.1016\/j.suc.2018.11.003_bib53","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib54","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.suc.2018.11.003_bib55","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1572-0241.2004.04047.x","article-title":"Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis","volume":"99","author":"Combes","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib56","article-title":"Azathioprine for primary biliary cirrhosis","author":"Gong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.suc.2018.11.003_bib57","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","article-title":"Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials","volume":"101","author":"Shi","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib58","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"issue":"20","key":"10.1016\/j.suc.2018.11.003_bib59","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A\u00a0controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.suc.2018.11.003_bib60","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1572-0241.2005.41522.x","article-title":"Colchicine for primary biliary cirrhosis: a Cochrane Hepato-Biliary Group systematic review of randomized clinical trials","volume":"100","author":"Gong","year":"2005","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.suc.2018.11.003_bib61","first-page":"342","article-title":"The histologic effects of low-dose methotrexate therapy for primary biliary cirrhosis","volume":"122","author":"Bach","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.suc.2018.11.003_bib62","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib66","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"issue":"5","key":"10.1016\/j.suc.2018.11.003_bib67","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broom\u00e9","year":"1995","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib68","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"Card","year":"2008","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib69","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.suc.2018.11.003_bib70","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/egh.09.53","article-title":"Hepatobiliary associations with inflammatory bowel disease","volume":"3","author":"Knight","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.suc.2018.11.003_bib71","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2004-828896","article-title":"Liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2004","journal-title":"Semin Liver Dis"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/PL00009950","article-title":"Is liver transplantation indicated for cholangiocarcinoma?","volume":"5","author":"Jeyarajah","year":"1998","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib73","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.suc.2018.11.003_bib74","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","article-title":"Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"82","author":"Heimbach","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.suc.2018.11.003_bib75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MOG.0b013e3282f706ce","article-title":"Successful liver transplantation for hilar cholangiocarcinoma","volume":"24","author":"Heimbach","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2018.11.003_bib76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00535-010-0317-2","article-title":"Serum IgG4-negative autoimmune pancreatitis","volume":"46","author":"Kamisawa","year":"2011","journal-title":"J\u00a0Gastroenterol"},{"issue":"12","key":"10.1016\/j.suc.2018.11.003_bib77","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961091830166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003961091830166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:10:47Z","timestamp":1758539447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003961091830166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S003961091830166X"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2018.11.003","relation":{},"ISSN":["0039-6109"],"issn-type":[{"type":"print","value":"0039-6109"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Diseases of the Biliary Tract","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2018.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}